Anti-rejection drug may eliminate skin cancer

03/31/2005 | NYTimes.com

The immunosuppressive drug sirolimus also reversed a skin cancer, Kaposi's sarcoma, which afflicts kidney transplant patients, according to a study in the New England Journal of Medicine. Fifteen patients who developed cancerous skin lesions while taking other anti-rejection drugs saw the lesions disappear with three months of switching to sirolimus.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN